Login / Signup

Hereditary angioedema patients would prefer newer-generation oral prophylaxis.

Daniela GebaJohan Mohd SaniMichaela GasconRebecca HahnKavita AggarwalJinky Rosselli
Published in: Journal of drug assessment (2021)
Most patients with HAE would prefer a newer generation oral prophylactic medication that would decrease treatment burden and allow them to live fuller lives.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • peritoneal dialysis
  • prognostic factors
  • emergency department
  • risk factors
  • patient reported outcomes